Paracrine prolactin may cause prostatic problems

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2266-2268

  Har̈könen, Pirkko ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROBASIN; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN; STEROID 5ALPHA REDUCTASE;

ACCESSORY SEX GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CASTRATION; CONFERENCE PAPER; CONTROLLED STUDY; EXPLANT; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSECTOMY; HYPOPHYSIS GRAFT; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MALE FERTILITY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE HYPERTROPHY; PROTEIN PROCESSING; RAT; SPERMATOGENESIS; TRANSGENIC MOUSE;

ANIMALS; HUMANS; MALE; PARACRINE COMMUNICATION; PROLACTIN; PROSTATIC DISEASES;

EID: 18544393953     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0354     Document Type: Conference Paper

References (35)

1. Costello LC, Franklin RB 1994 1994 Effect of prolactin on the prostate. Prostate 24:162-166
2. Reiter E, Hennuy B, Bruyninx M, Cornet A, Klug M, McNamara M, Closset J, Hennen G 1999 Effects of pituitary hormones on the prostate. Prostate 38:159-165
3. Goffin V, Binart N, Touraine P, Kelly PA 2002 Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67
4. Huggins C, Russell PS 1946 Quantitative effects of hypophysectomy on testis and prostate of dogs. Endocrinology 39:1-7
5. Grayhack JT 1963 Pituitary factors influencing growth of the prostate. NCI (Natl Cancer Inst) Monogr 12:189-199
6. Tangbanluekal L, Robinette CL 1993 Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats. Endocrinology 132:2407-2416
7. Nevalainen MT, Valve EM, Mäkelä SI, Bläuer M, Tuohimaa PJ, Härkönen PL 1991 Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinology 129:612-622
8. Nevalalnen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Härkönen PL 1997 Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest 99:618-627
9. Ahonen T, Härkönen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT 1999 Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140:5412-5421
10. Janssen T, Darro F, Petein M, Raviv G, Pasteels JL, Kiss R, Schulman CC 1996 In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 77:144-149
11. Ouhtit A, Morel G, Kelly PA 1993 Visualization of gene expression of short and long forms of prolactin receptor in rat reproductive tissues. Biol Reprod 49:528-536
12. Nevalainen MT, Valve EM, Ingleton PM, Härkönen PL 1996 Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate. Endocrinology 137:3078-3088
13. Leav I, Merk FB, Lee KF, Loda M, Mandoki M, McNeal JE, Ho SM 1999 Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions Am J Pathol 154:863-870
14. Nevalainen MT, Ahonen TJ, Yamashita H, Chandrashekar V, Bartke A, Grimley PM Robinson GW, Hennighausen L, Rui H 2000 Epithelial defect in prostates of Stat5a-null mice. Lab Invest 80:993-1006
15. Ahonen TJ, Härkönen PL, Rui H, Nevalainen MT 2002 PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro. Endocrinology 143:228-238
16. Eaton NE, Reeves GK, Appleby PN, Key TJ 1999 Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 80:930-934
17. Stattin P, Rinaldi S, Stenman UH, Riboli E, Hallmans G, Bergh A, Kaaks R 2001 Plasma prolactin and prostate cancer risk: a prospective study. Int J Cancer 92:463-465
18. Matzkin H, Kaver I, Lewyshon O, Ayalon D, Braf Z Cancer 1988 The role of increased prolactin levels under GnRH analogue treatment in advanced prostatic carcinoma. Cancer 61:2187-2191
19. Horti J, Figg WD, Weinberger B, Kohler D, Sartor O 1998 A phase II study of bromocriptine in patients with androgen-independent prostate cancer. Oncol Rep 5:893-896
20. Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J, Härkönen PL 1997 Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J 11:1297-1307
21. Compton MM, Witorsch RJ 1983 Proteolytic fragmentation of rat prolactin by the rat ventral prostate gland. Prostate 4:231-246
22. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669
23. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926-6935
24. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167-178
25. Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND 1998 Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139:3691-3695
26. Wennbo H, Kindblom J, Isaksson OGP, Törnell J 1997 Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138:4410-4415
27. Van Coppenolle F, Slomianny C, Carpentier F, Le Bourhis X, Ahidouch A, Croix D, Legrand G, Dewailly E, Fournier S, Cousse H, Authie D, Raynaud JP, Beauvillain JC, Dupouy JP, Prevarskaya N 2001 Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence. Am J Physiol Endocrinol Metab 280:E120-E129
28. Kindblom J, Dillner K, Sahlin L, Robertson F, Ormandy C, Törnell J, Wennbo H 2003 Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 144:2269-2278
29. Greenberg NM, DeMayo FJ, Sheooard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM 1994 The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239
30. Eaton CL 2003 Aetiology and pathogenesis of benign prostatic hyperplasia. Curr Opin Urol 1381:7-10
31. Prins GS 1987 Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate. Endocrinology 120:1457-1464
32. 3H]dihydrotestosterone by the rat prostate lobes. Endocrinology 110:920-925
33. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM 1997 Suppression of testosterone and estradiol-17 β-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 18:1505-1510
34. Xu X, Kreye E, Kuo CB, Walker AM 2001 A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res 61:6098-6104
35. Ron M, Finch A, Shapiro A, Caine M, Ben-David M 1981 Prolactin concentration in prostates with benign hypertrophy. Urology 17:235-237